Antihypertensive Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Antihypertensive Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Antihypertensive Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Antihypertensive market is expected to grow at a CAGR of 2.2% during the forecast period.
The global Antihypertensive market is estimated to be about 17483.1 million US dollars in 2020.
The global Antihypertensive market is estimated to reach 19089.3 million USD by 2026.
The global Antihypertensive market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Antihypertensive market will be able to gain an advantage as they use reports as a powerful resource.
Antihypertensive markets by category
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors
Antihypertensive Market by Application (Percentage of Demand)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Who are the leading companies in Antihypertensive
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical
Antihypertensive markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Antihypertensive.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Antihypertensive Revenue and Growth Forecast 2014-2026
2.2 Global Antihypertensive Market Size and Growth Forecast 2014-2026
2.3 Global Antihypertensive Revenue by Region 2014-2026
2.4 Antihypertensive Market Share by Major Regions 2014-2021
2.5 Antihypertensive Gross Margin in Different Region 2014-2021
2.6 Global Antihypertensive Market History Price and Forecast 2014-2026
2.7 Global Antihypertensive Sales Market Share by Top Companies 2014-2021
3 Global Antihypertensive Market by Type
3.1 Global Antihypertensive Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Antihypertensive Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Antihypertensive Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Diuretics
3.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors
3.4.3 Angiotensin Receptor Blockers (ARBs)
3.4.4 Calcium Channel Blockers
3.4.5 Beta Blockers
3.4.6 Alpha Blockers
3.4.7 Vasodilators & Renin Inhibitors
4 Global Antihypertensive Market by Application
4.1 Global Antihypertensive Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Antihypertensive Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Hospital Pharmacy
4.3.2 Retail Pharmacy
4.3.3 Online Pharmacy
4.3.4 Others
5 North America Antihypertensive Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Antihypertensive Value ($) from 2014-2021
5.2 North America Antihypertensive Market Size from 2014-2021
5.3 North America Antihypertensive Price Change from 2014-2021
5.4 North America Antihypertensive Import and Export from 2014-2021
5.5 North America Antihypertensive Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Antihypertensive Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Antihypertensive Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Antihypertensive Participants Value ($) and Market Share (%) in 2020
6 Europe Antihypertensive Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Antihypertensive Value ($) from 2014-2021
6.2 Europe Antihypertensive Market Size from 2014-2021
6.3 Europe Antihypertensive Price Change from 2014-2021
6.4 Europe Antihypertensive Import and Export from 2014-2021
6.5 Europe Antihypertensive Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Antihypertensive Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Antihypertensive Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Antihypertensive Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Antihypertensive Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Antihypertensive Value ($) from 2014-2021
7.2 Asia-Pacific Antihypertensive Market Size from 2014-2021
7.3 Asia-Pacific Antihypertensive Price Change from 2014-2021
7.4 Asia-Pacific Antihypertensive Import and Export from 2014-2021
7.5 Asia-Pacific Antihypertensive Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Antihypertensive Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Antihypertensive Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Antihypertensive Participants Value ($) and Market Share (%) in 2020
8 Latin America Antihypertensive Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Antihypertensive Value ($) from 2014-2021
8.2 Latin America Antihypertensive Market Size from 2014-2021
8.3 Latin America Antihypertensive Price Change from 2014-2021
8.4 Latin America Antihypertensive Import and Export from 2014-2021
8.5 Latin America Antihypertensive Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Antihypertensive Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Antihypertensive Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Antihypertensive Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Antihypertensive Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Antihypertensive Value ($) from 2014-2021
9.2 Middle East & Africa Antihypertensive Market Size from 2014-2021
9.3 Middle East & Africa Antihypertensive Price Change from 2014-2021
9.4 Middle East & Africa Antihypertensive Import and Export from 2014-2021
9.5 Middle East & Africa Antihypertensive Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Antihypertensive Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Antihypertensive Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Antihypertensive Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Pfizer Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Pfizer Value and Growth Change from 2014-2021
10.1.4 Pfizer Price Change from 2014-2021
10.1.5 Pfizer Product Offered
10.2 Norvatis
10.2.1 Norvatis Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Norvatis Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Norvatis Value and Growth Change from 2014-2021
10.2.4 Norvatis Price Change from 2014-2021
10.2.5 Norvatis Product Offered
10.3 Merck & Co.
10.3.1 Merck & Co. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Merck & Co. Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Merck & Co. Value and Growth Change from 2014-2021
10.3.4 Merck & Co. Price Change from 2014-2021
10.3.5 Merck & Co. Product Offered
10.4 Sanofi
10.4.1 Sanofi Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Sanofi Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Sanofi Value and Growth Change from 2014-2021
10.4.4 Sanofi Price Change from 2014-2021
10.4.5 Sanofi Product Offered
10.5 AstraZeneca
10.5.1 AstraZeneca Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 AstraZeneca Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 AstraZeneca Value and Growth Change from 2014-2021
10.5.4 AstraZeneca Price Change from 2014-2021
10.5.5 AstraZeneca Product Offered
10.6 GSK
10.6.1 GSK Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 GSK Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 GSK Value and Growth Change from 2014-2021
10.6.4 GSK Price Change from 2014-2021
10.6.5 GSK Product Offered
10.7 Daiichi-Sankyo
10.7.1 Daiichi-Sankyo Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Daiichi-Sankyo Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Daiichi-Sankyo Value and Growth Change from 2014-2021
10.7.4 Daiichi-Sankyo Price Change from 2014-2021
10.7.5 Daiichi-Sankyo Product Offered
10.8 Boehringer-Ingelheim
10.8.1 Boehringer-Ingelheim Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Boehringer-Ingelheim Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Boehringer-Ingelheim Value and Growth Change from 2014-2021
10.8.4 Boehringer-Ingelheim Price Change from 2014-2021
10.8.5 Boehringer-Ingelheim Product Offered
10.9 Bayer
10.9.1 Bayer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Bayer Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Bayer Value and Growth Change from 2014-2021
10.9.4 Bayer Price Change from 2014-2021
10.9.5 Bayer Product Offered
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Johnson & Johnson Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Johnson & Johnson Value and Growth Change from 2014-2021
10.10.4 Johnson & Johnson Price Change from 2014-2021
10.10.5 Johnson & Johnson Product Offered
10.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Bristol-Myers Squibb Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Bristol-Myers Squibb Value and Growth Change from 2014-2021
10.11.4 Bristol-Myers Squibb Price Change from 2014-2021
10.11.5 Bristol-Myers Squibb Product Offered
10.12 Tekeda
10.12.1 Tekeda Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Tekeda Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Tekeda Value and Growth Change from 2014-2021
10.12.4 Tekeda Price Change from 2014-2021
10.12.5 Tekeda Product Offered
10.13 Ranbaxy Laboratories
10.13.1 Ranbaxy Laboratories Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Ranbaxy Laboratories Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Ranbaxy Laboratories Value and Growth Change from 2014-2021
10.13.4 Ranbaxy Laboratories Price Change from 2014-2021
10.13.5 Ranbaxy Laboratories Product Offered
10.14 Shihuida Pharm
10.14.1 Shihuida Pharm Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Shihuida Pharm Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Shihuida Pharm Value and Growth Change from 2014-2021
10.14.4 Shihuida Pharm Price Change from 2014-2021
10.14.5 Shihuida Pharm Product Offered
10.15 Second Pharmaceutical
10.15.1 Second Pharmaceutical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 Second Pharmaceutical Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 Second Pharmaceutical Value and Growth Change from 2014-2021
10.15.4 Second Pharmaceutical Price Change from 2014-2021
10.15.5 Second Pharmaceutical Product Offered
10.16 Lupin Limited.
10.16.1 Lupin Limited. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 Lupin Limited. Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 Lupin Limited. Value and Growth Change from 2014-2021
10.16.4 Lupin Limited. Price Change from 2014-2021
10.16.5 Lupin Limited. Product Offered
10.17 Yangtze River Pharmaceutical
10.17.1 Yangtze River Pharmaceutical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Yangtze River Pharmaceutical Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Yangtze River Pharmaceutical Value and Growth Change from 2014-2021
10.17.4 Yangtze River Pharmaceutical Price Change from 2014-2021
10.17.5 Yangtze River Pharmaceutical Product Offered
10.18 Hengrui Medicine
10.18.1 Hengrui Medicine Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Hengrui Medicine Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Hengrui Medicine Value and Growth Change from 2014-2021
10.18.4 Hengrui Medicine Price Change from 2014-2021
10.18.5 Hengrui Medicine Product Offered
10.19 Qilu Pharmaceutical
10.19.1 Qilu Pharmaceutical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 Qilu Pharmaceutical Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 Qilu Pharmaceutical Value and Growth Change from 2014-2021
10.19.4 Qilu Pharmaceutical Price Change from 2014-2021
10.19.5 Qilu Pharmaceutical Product Offered
10.20 HUALON
10.20.1 HUALON Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.20.2 HUALON Sales, Value, Gross and Gross Margin from 2014-2021
10.20.3 HUALON Value and Growth Change from 2014-2021
10.20.4 HUALON Price Change from 2014-2021
10.20.5 HUALON Product Offered
10.21 Dawnrays
10.21.1 Dawnrays Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.21.2 Dawnrays Sales, Value, Gross and Gross Margin from 2014-2021
10.21.3 Dawnrays Value and Growth Change from 2014-2021
10.21.4 Dawnrays Price Change from 2014-2021
10.21.5 Dawnrays Product Offered
10.22 HISUN Pharmceutical
10.22.1 HISUN Pharmceutical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.22.2 HISUN Pharmceutical Sales, Value, Gross and Gross Margin from 2014-2021
10.22.3 HISUN Pharmceutical Value and Growth Change from 2014-2021
10.22.4 HISUN Pharmceutical Price Change from 2014-2021
10.22.5 HISUN Pharmceutical Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Antihypertensive by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Antihypertensive Market from 2020-2026
12.1 Future Forecast of Global Antihypertensive Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Antihypertensive Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Antihypertensive Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Antihypertensive Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|